Bilcare Academy Event to Kick Off

“Bilcare Academy” Event to Kick Off Contract Pharma’s 15th Annual Contracting and Outsourcing Conference in September

Bilcare Research experts to deliver featured presentation: “The Role of Packaging Materials in Pharmaceutical Product Stability”

Bilcare Research Inc., one of the world’s largest manufacturers of blister packaging solutions, will host an educational event, dubbed Bilcare Academy, covering a range of topics dealing with the crucial role that packaging plays in the pharmaceutical life cycle. The event will take place at the Hyatt Regency in New Brunswick, NJ on September 21 – a day before the 15th Annual Contract Pharma Contracting and Outsourcing Conference & Tabletop Exhibition.

Bilcare Academy will entail in-depth discussions concerning the use of scientific models in packaging design to expedite the development process and overcome existing resource challenges, as well as a special 11:00am luncheon presentation, titled “The Role of Packaging Materials in Pharmaceutical Product Stability.”
To register for Bilcare Academy, contact Bilcare Research by emailing Chuck.Newswanger@bilcare.com, or calling (302) 256-7089.

Among other topics, industry packaging experts will discuss trends in high-barrier blister materials, consideration of sustainability in pharmaceutical packaging, and the company’s groundbreaking methods for streamlining paths to optimum product packaging.

Bilcare Research Segregates Pharma-Related Production Operations

Bilcare Research Inc., a division of one of the world’s largest manufacturers of blister packaging solutions, has begun segregating pharma-related production operations from those servicing other industries at its Wilmington, DE facility. The decision showcases Bilcare‘s commitment to the pharmaceutical sector amid growing customer demand and heightened quality control expectations.
Part of the global Pharmaceutical Packaging Innovation (PPI) Business Unit of Bilcare Research AG,   Bilcare Research offers a variety of mono and barrier blister films to the pharmaceutical packaging industry.  In addition to manufacturing pharmaceutical blister films, the company also produces products for other business units of the company.

With growing customer demand and a steadily increasing market share in the pharmaceutical films sector, Bilcare’s effort to separate its PPI production and storage area from areas servicing other businesses has the purpose of clearly differentiating its production process along industry-specific lines.  The result is the ability to service all sectors more efficiently.

Distributional

“We are dedicated to our pharmaceutical customers and this is just one more example of how,” said Kevin Stevens, President and Managing Director of Bilcare Research Inc. “Our strategy is to exceed our customers’ expectations in the quality of Bilcare’s products; the new plant layout shows our commitment and investment to that end. Packaging pharmaceutical products in an ideal fashion calls for a dedicated, siloed production environment throughout the supply chain, and we aim to set the bar high toward that goal.”